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Abstract
Objective:  To  evaluate  the  effect  of  maternal  supplementation  with  vitamin  E  on  the  concen-
tration of  -tocopherol  in  colostrum  and  its  supply  to  the  newborn.
Method:  This  randomized  clinical  trial  enrolled  99  healthy  adult  pregnant  women;  of  these,
39 were  assigned  to  the  control  group  and  60  to  the  supplemented  group.  After  an  overnight
fast, 5  mL  of  blood  and  2  mL  of  colostrum  were  collected.  After  the  ﬁrst  sampling  (0  h  milk),  the
supplemented  group  received  400  IU  of  supplementary  vitamin  E.  Another  2  mL  milk  aliquot  was
collected in  both  groups  24  h  after  supplementation  (24  h  milk).  The  samples  were  analyzed  by
high-performance  liquid  chromatography.  The  -tocopherol  content  provided  by  colostrum  was
calculated by  considering  a  daily  intake  of  396  mL  of  milk  and  comparing  the  resulting  value  to
the recommended  daily  intake  for  infants  aged  0--6  months  (4  mg/day).
Results:  The  initial  mean  concentration  of  -tocopherol  in  colostrum  was  1509.3  ±  793.7  g/dL
in the  control  group  and  1452.9  ±  808.6  g/dL  in  the  supplemented  group.  After  24  h,  the
mean -tocopherol  concentration  was  1650.6  ±  968.7  g/dL  in  the  control  group  (p  >  0.05)  and
2346.9 ±  1203.2  g/dL  in  the  supplemented  group  (p  <  0.001),  increasing  the  vitamin  E  supply  to
the newborn  to  9.3  mg/day.  Initially,  18  women  in  the  supplemented  group  provided  colostrum
-tocopherol  contents  below  4  mg/day;  after  supplementation  only  six  continued  to  provide
less than  the  recommended  amount.
 Please cite this article as: Melo LR, Clemente HA, Bezerra DF, Dantas RC, Ramalho HM, Dimenstein R. Effect of maternal supplementation
ith vitamin E on the concentration of -tocopherol in colostrum. J Pediatr (Rio J). 2017;93:40--6.
 Study carried out at Universidade Federal do Rio Grande do Norte (UFRN), Natal, RN, Brazil.
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Conclusion:  Maternal  vitamin  E  supplementation  increases  the  supply  of  the  vitamin  to  the
infant by  providing  more  than  twice  the  Recommended  Daily  Intake.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Efeito  da  suplementac¸ão materna  com  vitamina  E  sobre  a  concentrac¸ão de
-tocoferol  no  colostro
Resumo
Objetivo:  Avaliar  o  efeito  da  suplementac¸ão  materna  com  vitamina  E  sobre  a  concentrac¸ão  de
-tocoferol  no  colostro  e  o  fornecimento  desta  para  o  recém-nascido.
Método:  O  estudo  clínico  randomizado  foi  realizado  com  99  parturientes  adultas  e  saudáveis,
sendo 39  alocadas  no  grupo  controle  e  60  no  grupo  suplementado.  Após  jejum  noturno,  foram
coletadas 5  mL  de  sangue  e  2  mL  de  colostro  das  parturientes.  Após  a  primeira  coleta  (leite
0 h),  o  grupo  suplementado  recebeu  suplementac¸ão  com  400  UI  de  vitamina  E.  Foi  realizada
nova coleta  de  2  mL  de  colostro,  em  ambos  os  grupos,  24  h  após  a  suplementac¸ão  (leite  24  h).
As amostras  foram  analisadas  por  Cromatograﬁa  Líquida  de  Alta  Eﬁciência.  A  quantidade  de
-tocoferol  fornecida  pelo  colostro  foi  considerada  para  uma  ingestão  diária  de  396  mL  de  leite
e comparada  com  a  Ingestão  Diária  Recomendada  para  crianc¸as  de  0  a  6  meses  (4  mg/dia).
Resultados:  A  concentrac¸ão  média  inicial  de  -tocoferol  no  colostro  foi  1509,3  ±  793,7  g/dL
no grupo  controle  e  1452,9  ±  808,6  g/dL  no  grupo  suplementado.  Após  24  horas  a  concentrac¸ão
média de  -tocoferol  no  grupo  controle  foi  1650,6  ±  968,7  g/dL  (p  >  0,05),  já  no  grupo  suple-
mentado a  concentrac¸ão  média  foi  2346,9  ±  1203,2  g/dL  (p  <  0,001),  aumentando  assim  a
oferta de  vitamina  E  para  o  recém-nascido  para  9,3  mg/dia.  Inicialmente  18  mulheres  do  grupo
suplementado  forneciam  valores  inferiores  a  4  mg/dia  de  -tocoferol  em  seu  colostro,  após
suplementac¸ão apenas  6  continuaram  a  fornecer  quantidade  inferior  ao  recomendado.
Conclusão:  A  suplementac¸ão  materna  com  vitamina  E  promove  o  aumento  do  fornecimento  da
vitamina  para  o  recém-nascido,  fornecendo  mais  do  que  o  dobroda  Ingestão  Diária  Recomen-
dada.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
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Introduction
Vitamin  E  is  the  generic  term  used  to  describe  eight  differ-
ent  molecules:  -,  -,  -,  and  -tocopherol  and  -,  -,  -,
and  -tocotrienol.1 Among  them,  -tocopherol  is  the  only
isomer  related  to  nutritional  needs  of  vitamin  E.  Vitamin  E
is  considered  one  of  the  best  biological  antioxidants  due  to
the  protection  offered  to  the  plasma  membrane  and  low-
density  lipoproteins  against  oxidation  reactions  and  lipid
peroxidation.2
Newborns  are  considered  high-risk  for  vitamin  E  deﬁ-
ciency  due  to  oxidative  stress  generated  by  postnatal
transition  from  the  intrauterine  environment,  relatively  low
in  oxygen,  to  the  extrauterine  one,  signiﬁcantly  richer  in
oxygen.3 Considering  this  vitamin  deﬁciency  risk,  it  is  rec-
ommended  that  the  -tocopherol  intake  during  the  ﬁrst  six
months  of  the  infant’s  life  be  4  mg/day.4
It  is  known  that  the  placental  transfer  of  -tocopherol
from  the  mother  to  the  infant  is  limited,  even  if  there  is
an  increase  in  maternal  intake  of  vitamin  E.5 Thus,  the
newborn  may  have  low  reserves  of  vitamin  E,  making  it
necessary  that  breast  milk  provide  an  adequate  amount
of  vitamin  E  to  ensure  the  formation  of  vitamin  reserves
and  reinforce  the  newborn’s  defenses  against  oxidative
stress.6
T
-
CInsufﬁcient  intake  of  this  nutrient  at  this  stage  of  life
especially  from  the  6th  to  8th  week)  can  affect  the  devel-
pment  of  the  immune  and  pulmonary  systems.7 However,
f  regular  breastfeeding  occurs,  nutritional  deﬁciency  symp-
oms  are  generally  not  observed  in  children.8
Venous  supplementation  with  high  doses  of  vitamin  E  in
nfants  increases  the  risk  of  sepsis  and  reduces  supplemen-
ation  efﬁciency  in  ﬁghting  severe  retinopathy.9 Therefore,
aternal  supplementation  to  improve  the  nutritional  status
f  the  neonate  through  satisfactory  amounts  of  -tocopherol
rovided  by  colostrum  becomes  the  safest  way  to  prevent
ossible  vitamin  E  deﬁciency,  as  it  will  be  slowly  released
uring  the  feedings,  contributing  to  the  formation  of  body
eserves,  since  placental  transfer  is  limited.6
Thus,  the  aim  of  this  study  was  to  investigate  the  effect
f  maternal  supplementation  with  vitamin  E  on  the  concen-
ration  of  -tocopherol  in  colostrum  and  consequently  on
he  supply  of  this  vitamin  for  the  neonate.
ethods
thical  considerations
he  study  was  approved  by  the  Research  Ethics  Committee
-  REC  da  Universidade  Federal  do  Rio  Grande  do  Norte  --
AAE  0260.0.051.294-11.
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tudy  population
or  the  calculation  of  the  required  minimum  sample  size,
eductive  power  analysis  was  used,  through  GPower® soft-
are,  version  3  (G  Power®,  Germany).  The  parameters  taken
nto  consideration  were:  effect  size  d  =  0.5,  probability  of
rror  ˛  = 0.05,  power  test  ˇ  =  0.95,  and  a  95%  conﬁdence
nterval.  Using  these  parameters,  the  minimum  required
ample  consisted  of  22  subjects  for  each  group.  A  total  of
9  adult  and  healthy  pregnant  women  participated  in  this
tudy;  39  were  allocated  to  the  control  group  and  60  to  the
upplemented  group.
Sampling  was  carried  out  by  convenience,  comprising
regnant,  female  volunteers  aged  18--40  years,  without
athologies  (diabetes,  hypertension,  cancer,  diseases  of
he  gastrointestinal  tract,  liver,  heart  diseases,  infections,
yphilis  and/or  HIV  positive),  who  had  delivered  a  full-term,
ingle  infant  without  malformations  and  did  not  use  vitamin
upplements  during  pregnancy.
tudy  design
he  randomized  clinical  trial  was  carried  out  from  Jan-
ary  2012  to  March  2013,  at  the  Maternity  School,  in  Brazil.
omen  that  met  the  research  criteria  were  invited  to  partic-
pate  in  the  study  and  signed  the  Free  and  Informed  Consent
FIC).
Every  mother  who  accepted  to  participate  in  the  study
as  allocated  to  a  group,  i.e., the  control  group  (CG)  or
he  supplemented  group  (SG),  by  drawing  lots,  with  the
atter  receiving  capsules  containing  400  international  units
IU)  of  alpha-tocopherol.  Randomization  was  used  so  that
ll  women  would  have  the  same  chance  of  being  sorted  to
ither  of  the  two  groups.
Blood  (5  mL)  and  colostrum  milk  (2  mL)  were  collected
rom  each  participant  in  the  morning  hours  after  an
vernight  fast.  The  collection  of  milk  occurred  in  two  stages,
he  ﬁrst  (0  h)  at  the  initial  contact  with  the  mother  and  the
econd  24  hours  (24  h)  after  the  ﬁrst  collection.  The  moth-
rs  belonging  to  the  supplemented  group  received  a  capsule
ontaining  400  IU  of  alpha  tocopherol,  respectively,  after  the
rst  milk  collection  (0  h).
The  data  related  to  maternal  and  neonatal  characteris-
ics  were  obtained  from  ﬁles.
ample  collection  and  preparation
lood  collected  by  venipuncture  (5  mL)  by  nurses  on  duty  at
he  maternity  were  placed  in  polypropylene  tubes  protected
rom  light  and  transported  to  the  laboratory  under  refriger-
tion;  they  were  then  centrifuged  to  remove  of  1000  L  of
erum,  then  stored  at  −18 ◦C.
Colostrum  was  obtained  by  manual  expression  of  one
reast,  always  at  the  end  of  the  feeding  to  prevent  ﬂuc-
uations  in  fat  and  tocopherol  content.  The  foremilk  was
iscarded  and  2  mL  were  collected  at  time  0  h  and  another
 mL  sample  after  24  h.  These  procedures  were  performed
y  the  study  authors  themselves.  As  for  the  supplemented
omen,  milk  samples  were  collected  24  h  after  supple-
entation.  The  samples  were  collected  in  polypropylene
ubes  protected  from  the  light  and  transported  under
r
m
c
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efrigeration,  then  were  sent  to  the  laboratory;  colostrum
amples  were  placed  in  a  water  bath  at  37 ◦C  for  15  min  and
omogenized  and  then  a  500  L  sample  was  removed  and
tored  at  −18 ◦C.
rocedures  for  the  analysis
he  technique  used  for  extracting  the  tocopherol  in  serum
as  adapted  from  Ortega  et  al.10 To  2  mL  of  serum,  an
qual  amount  of  95%  ethanol  was  added,  the  mixture  was
tirred,  and  2  mL  of  hexane  were  added  for  three  extrac-
ion  steps;  each  of  the  steps  was  stirred  and  centrifuged
10  min,  1073  ×  g),  and  the  organic  phase  containing  hexane
as  separated,  totaling  6  mL.
The  methodology  adapted  from  Romeu-Nadal  et  al.11 was
sed  for  the  milk.  To  0.5  mL  of  colostrum  was  added  0.5  mL
f  95%  ethanol.  Next,  the  tube  was  submitted  to  mechanical
gitation  for  1  min  and  the  extraction  process  was  performed
n  two  steps  with  2  mL  of  hexane,  resulting  in  a  4  mL  extrac-
ion  of  the  hexane  phase.
Of  the  organic  compounds  obtained  from  both  sam-
les,  2  mL  were  evaporated  using  nitrogen,  and  the  dried
xtract  was  dissolved  in  0.5  mL  of  absolute  ethanol  for  fur-
her  analysis  by  High  Performance  Liquid  Chromatography
HPLC).
The  -tocopherol  concentrations  were  determined  by
PLC  in  a  Shimadzu® LC-20AT  (Shimadzu®,  USA)  chro-
atograph,  equipped  with  a  20  L  loop  injector,  CBM  20  A
Shimadzu®,  USA)  communicator,  and  coupled  to  a  SPD-
0A  UV-VIS  detector  (Shimadzu®,  USA),  with  UV  detection
max =  292  nm).
The  chromatographic  separation  was  carried  out  in  an
C  Shim-Pack® CLC-ODS  (Shimadzu®, USA)  4.6  mm  ×  25  cm
eversed  phase-column.  The  elution  was  isocratic  with  a
obile  phase,  consisting  of  methanol/ultrapure  water  (Milli-
®,  Millipore  Sigma®,  Merck,  Germany)  in  97:3  (v:v)  with  a
.0  mL/min  ﬂow.  The  chromatograms  were  integrated  using
he  LC  Solution® program  (Shimadzu®, USA).
The  identiﬁcation  and  quantiﬁcation  of  the  -tocopherol
n  the  samples  was  established  by  comparison  of  the  peak
etention  area  obtained  in  the  chromatogram  with  the  area
f  the  respective  SIGMA® (Sigma®, Merck,  Germany)  alpha-
ocopherol  standard.  The  concentration  of  the  standard  was
onﬁrmed  by  the  speciﬁc  extinction  coefﬁcient  in  absolute
thanol,  ε  1%,  1  cm  =  75.8.
onﬁrmation  of  capsule  concentration
o  verify  whether  the  capsules  contained  400  IU  of  Vitamin
,  they  were  opened  and  then  an  aliquot  of  each  capsule
as  weighed,  which  was  placed  in  a  polypropylene  tube  pro-
ected  from  light  and  added  to  1  mL  of  HPLC  grade  Ethanol.
IGMA® (Sigma®,  Merck,  Germany)  -tocopherol  was  simi-
arly  produced.
The  identiﬁcation  and  quantiﬁcation  of  the  -tocopherol
n  the  capsules  were  established  by  comparing  the  peak
rea  obtained  in  the  chromatogram  with  the  area  of  the
espective  alpha-tocopherol  SIGMA® (Sigma®,  Merck,  Ger-
any)  standard,  as  well  as  through  the  speciﬁc  extinction
oefﬁcient  in  absolute  ethanol  of  -tocopherol  acetate  ε  1%,
 cm  =  40.
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When  assessing  the  -tocopherol  concentrations  in  the
colostrum  of  supplemented  women  who  could  not  provide
the  recommended  values  in  their  milk  even  after  ingestion
of  400  IU  of  vitamin  E,  it  was  veriﬁed  that  these  mothers
Table  1  Supply  of  -tocopherol  (mg/day)  from  colostrum
at 0  h  and  24  h,  according  to  the  experimental  groups.
Group  [-TOH]
colostrum  0  h
[-TOH]
colostrum  24  h
p-value
CG  5.9  mg/day  6.5  mg/day  0.33Maternal  supplementation  with  -tocopherol  
The  capsules  contained  -tocopherol  at  the  concen-
trations  stated  on  their  labels,  demonstrating  the  actual
amount  provided  by  the  capsule.
Statistical  analysis
Statistica  7  software  (StatSoft  Inc.,  USA)  was  used  for  sta-
tistical  analysis.  Alpha-tocopherol  values  were  expressed
as  mean  and  standard  deviation.  To  test  the  differences
between  the  means  of  parametric  numerical  data,  Stu-
dent’s  t-test  was  used  in  paired  samples.  Differences
were  considered  signiﬁcant  at  p  <  0.05.  The  association
between  continuous  variables  (concentration  of  nutrients  in
milk  and  serum)  was  determined  by  Pearson’s  correlation
analysis.
Nutritional  needs
The  amount  of  -tocopherol  provided  by  colostrum  was  con-
sidered  for  a  daily  intake  of  396  mL  of  milk,  related  to  the
average  production  of  milk  during  the  ﬁrst  week  after  deliv-
ery  of  mothers  that  had  full-term  newborns  and  compared
with  the  dietary  reference  intake  (DRI)  for  children  aged  0--6
months,  the  equivalent  to  4  mg/day.4,12
Results
Description  of  the  population
A  total  of  99  women  participated  in  the  study,  with  39  allo-
cated  to  the  control  group  and  60  to  the  supplemented
group.
The  mean  age  in  years  was  24  ±  6,  most  were  married
or  living  in  a  stable  union  (65%),  and  the  level  of  education
was  varied:  36%  of  women  did  not  complete  primary  educa-
tion,  whereas  only  0.9%  attended  college/university.  Family
income  ranged  between  1  and  4  minimum  wages  (81.4%).
The  mean  number  of  residents  in  the  households  of  pregnant
women  was  5.4  ±  1.6  people,  with  a  minimum  value  of  2  and
maximum  of  10.
Regarding  obstetric  variables,  53.1%  of  women  had  had
another  pregnancy;  the  main  type  of  delivery  was  cesarean
section  (58.1%)  with  a  mean  of  39.1  ±  1.4  weeks  of  ges-
tation.  Most  women  started  the  pregnancy  with  a  normal
weight  (51.2%);  however,  there  was  a  trend  for  increased
weight  gain  totaling  46.1%  of  women  with  overweight  and
obesity  at  the  end  of  the  pregnancy.
Concentrations  of  -tocopherol  in  serum
The  mothers  had  a  mean  concentration  of  -tocopherol
in  serum  of  1066.6  ±  287.7  mg/dL  and  1159.6  ±  350  mg/dL,
respectively  in  the  CG  and  SG,  with  no  signiﬁcant
difference  (p  =  0.41)  between  them.  Overall,  6.1%  of  par-
ticipants  (n  =  6)  had  serum  levels  indicating  low  levels
of  -tocopherol  (ranging  from  499.6  to  697.7  mg/dL),
while  3.0%  (n  =  3)  had  -tocopherol  deﬁciency  (lev-
els  <  499.6  mg/dL).1343
oncentrations  of  -tocopherol  in  colostrum  and
esponse to  supplementation
he  mothers  had  a  mean  concentration  of  -tocopherol
n  colostrum  of  1509.3  ±  793.7  and  1452.9  ±  808.6  mg/dL
espectively,  in  the  CG  and  SG  groups  at  time  0  h.  It  was
ound  that  the  concentrations  of  -tocopherol  were  sim-
lar  in  all  groups,  with  no  evidence  that  the  mean  levels
n  the  groups  at  0  h  were  different  (p  =  0.74).  This  fact
orroborates  the  homogeneity  of  the  groups,  showing  that
articipants  initially  had  similar  -tocopherol  concentra-
ions  in  colostrum.
After  supplementation,  the  mean  concentration  of  -
ocopherol  in  the  mothers’  colostrum  was  1650.6  ±  968.7
nd  2346.9  ±  1203.2  mg/dL  in  the  CG  and  SG  groups,  respec-
ively.
When  comparing  the  concentrations  of  -tocopherol  in
olostrum  at  times  0  h  and  24  h,  it  was  observed  that  women
ho  did  not  receive  supplementation  (CG)  showed  similar
oncentrations  at  both  moments  (p  =  0.33).  However,  the
ean  -tocopherol  concentrations  in  supplemented  women
ncreased  the  concentration  of  -tocopherol  secreted  in
olostrum  by  61%  (p  <  0.001).
ewborn’s  nutritional  needs
efore  supplementation,  the  CG  and  SG  groups  provided
mounts  of  -tocopherol  respectively  greater  than  4  mg/day
ecommended  for  children  aged  0--6  months  (Table  1).  The
owest  value  was  0.66  mg  and  the  highest  was  14.9  mg  of
-tocopherol  for  396  mL  of  colostrum.
In  the  control  group  (CG),  the  mean  -tocopherol  supply
emained  unchanged,  as  this  group  received  no  supple-
entation,  whereas  the  SG  group,  which  received  the
upplementation,  started  to  provide  on  average  3.6  mg/day
ore  -tocopherol  for  396  mL  of  colostrum  24  h  after  supple-
entation.
When  individually  analyzing  the  women  in  the  control
roup,  33%  (n  =  13)  showed  values  below  4  mg/day  of  -
ocopherol  in  their  colostrum  before  the  supplementation,
hile  30%  (n  =  18)  of  the  supplemented  group  of  women
ad  the  same  amount  of  vitamin  E.  After  supplemen-
ation,  only  10%  of  the  women  (n  =  6)  showed  values  below
he  4 mg  of  -tocopherol  for  the  newborn,  while  in  the
G,  28%  (n  =  11)  of  women  still  did  not  provide  adequate
mounts.SG 5.7  mg/day  9.3  mg/day  <0.001
CG, control group; SG, supplementation group; -TOH, alpha-
tocopherol.
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ad  in  common  an  initial  concentration  of  -tocopherol  in
olostrum  lower  than  2  mg  for  396  mL.
iscussion
he  health  of  pregnant  women  and  newborns  depends  on
dequate  maternal  nutrition.  Nutrition  during  pregnancy
s,  therefore,  decisive  for  the  gestational  course  and  the
ormation  of  reserves  for  lactation.  During  pregnancy,  symp-
oms  such  as  nausea,  vomiting,  and  heartburn  may  cause
 reduction  in  food  intake,  especially  considering  that  fats
re  not  well  tolerated.14 The  reduction  of  this  intake  can
ead  to  reduced  consumption  of  -tocopherol  and,  thus,  it  is
mportant  to  verify  if  the  mother  has  nutritionally  adequate
lasma  concentrations  of  this  vitamin.
According  to  Sauberlich  et  al.,13 the  concentration  of
-tocopherol  in  serum  must  be  greater  than  or  equal  to
97  mg/dL.  Based  on  these  reference  values,  the  study
howed  an  average  concentration  considered  to  be  accept-
ble  regarding  -tocopherol  parameters  in  serum.  Similar
oncentrations  were  found  in  the  studies  by  Papas  et  al.,15
arcia  et  al.,16 and  Dimenstein  et  al.17
When  individually  analyzing  the  breastfeeding  mothers,
.1%  of  them  had  low  nutritional  status  for  -tocopherol,  a
ifferent  prevalence  from  that  in  the  study  by  de  Lira  et  al.18
arried  out  at  the  same  hospital,  which  found  a  percentage
f  12%  of  women  with  -tocopherol  deﬁciency.  This  differ-
nce  can  be  explained  by  the  participation  of  adolescents
n  the  sample  group.
The  concentration  of  -tocopherol  in  0  h  colostrum  of
he  two  groups  was  within  the  expected  when  compared
o  studies  carried  out  in  Brazil  by  Dimenstein  et  al.,17
ho  found  an  average  concentration  of  -tocopherol
f  1603.4  ±  911  mg/dL,  and  Campos  et  al.,19 who  found
313.9  ±  798.7  mg/dL.  Studies  in  the  United  States20 and
urkey21 showed  similar  results  to  those  in  this  work,  with
-tocopherol  values  in  colostrum  of  1335.2  ±  198.1  and
326.6  ±  68.9  mg/dL,  respectively.
Regarding  the  effect  of  using  vitamin  E  supplements  on
he  increase  in  -tocopherol  in  breast  milk,  studies  with
umans  are  still  controversial.
Szlagatys-Sidorkiewicz  et  al.,22 in  a  study  conducted  in
oland,  showed  that  the  concentration  of  vitamin  E  in
ilk  was  not  higher  in  women  who  received  recommended
itamin  supplements  for  pregnant  and  lactating  women  com-
ared  to  those  who  did  not  (p  =  0.332).  Also  in  Poland,
artysiak-Zurowska  et  al.23 obtained  similar  results,  show-
ng  no  correlation  between  dietary  intake  of  vitamin  E  and
he  use  of  supplements  with  the  concentration  of  alpha-
ocopherol  in  breast  milk.
However,  a  study  in  Canada  found  that  there  was  a
ositive  correlation  between  vitamin  E  found  in  milk  and
ultivitamin  supplementation  reported  by  the  research
articipants.24 In  a  study  of  the  Brazilian  population,  Garcia
t  al.25 observed  that  24  h  after  vitamin  E  supplementation
here  was  a  signiﬁcant  increase  in  the  amount  of  alpha-
ocopherol  in  colostrum  (p  =  0.04).Based  on  the  established  reference  values  for  -
ocopherol  intake,  the  groups  provided  on  average
uantities  >4  mg/day,  whereas  the  supplemented  group
howed  an  increase  of  61.5%.
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However,  no  one  knows  with  certainty  whether  4  mg/day
f  -tocopherol  is  sufﬁcient  at  this  stage  of  lactation,  since
or  the  determination  of  -tocopherol  DRI  for  infants  aged
--6  months,  only  the  average  intake  of  this  nutrient  was
nalyzed  after  two  months  of  lactation.4 Thus,  the  ﬁrst
onth  of  life  has  not  been  accounted  for,  a  phase  in  which
he  newborn  experiences  an  imbalance  of  the  antioxidant
ystem  due  to  the  transition  to  the  extrauterine  environ-
ent,  which  is  signiﬁcantly  richer  in  oxygen.3
In  addition  to  this  increased  risk  of  oxidative  stress,  it
s  necessary  to  take  into  account  certain  factors  that  cause
ariations  in  nutrient  intake  from  colostrum,  such  as  dif-
erences  in  the  milk  intake  volume  and  concentration  of
utrients  during  early  lactation,  factors  that  were  not  con-
idered  to  establish  the  DRI,  which  may  underestimate  the
eonate’s  real  needs.
Studies  on  the  beneﬁts  of  -tocopherol  supplementation
n  newborns  are  still  scarce;  however,  it  has  been  reported
hat  supplementation  in  the  group  of  low  birth  weight
nfants  has  shown  beneﬁts  that  go  beyond  the  reduction
f  oxidative  stress.  Kitajima  et  al.26 found  that  supplemen-
ation  with  -tocopherol  can  improve  mental  development
f  infants  with  low  birth  weight,  especially  regarding  IQ
erformance  at  school  age,  indicating  that  -tocopherol
ay  be  an  essential  nutrient  for  mental  development  in
hildhood.
This  study  is  in  accordance  with  the  results  found  by  Chen
t  al.27 that,  while  assessing  the  levels  of  vitamin  A,  C,  and
 in  the  mother  and  child,  found  that  newborn’s  levels  of
-tocopherol  were  directly  associated  to  motor,  behavioral
evelopment,  and  developmental  quotient.
However,  it  is  known  that  premature  infants  have  a  higher
isk  of  developing  complications  resulting  from  intravenous
upplementation  with  vitamin  E,  such  as  the  development  of
epsis  and  necrotizing  enterocolitis.28 Faced  with  this  risk,
t  would  be  safer  to  recommend  maternal  supplementation
f  -tocopherol,  with  the  vitamin  being  transferred  to  the
nfant  through  breast  milk.  It  is  known  that  breast  milk  offers
everal  beneﬁts  to  the  newborn,  as  it  is  a  nutritionally-rich
ood  and  is  free  from  impurities,  being  able  to  reduce  mor-
idity  and  mortality  and  promote  health  beneﬁts  in  the  long
erm.29
Based  on  the  results  observed  in  the  study,  it  was
ound  that  the  mothers  of  the  assessed  population  provided
ocopherol  levels  above  the  adequate  intake  (AI)  before
upplementation;  however,  such  supply  was  increased  by
1.5%  after  supplementation.
This  increase  in  vitamin  supply  was  also  observed  by
lement  et  al.30 in  women  supplemented  with  vitamin  E
apsules  in  either  natural  or  synthetic  form;  however,  with
etter  results  than  those  who  received  RRR--tocopherol
apsules.
In women  whose  -tocopherol  concentrations  in  breast
ilk  were  less  than  4  mg/day,  an  increase  of  vitamin  E  in  milk
ccurred  after  supplementation  similarly  to  the  other  moth-
rs;  however,  due  to  the  low  initial  levels  of  the  vitamin,  it
ailed  to  meet  the  infant’s  nutritional  needs.
Maternal  supplementation  provides  an  increase  in  the
upply  of  -tocopherol,  which  brings  beneﬁts  to  the  new-
orn,  contributing  to  the  neonate’s  motor  and  mental
evelopment,26,27 as  well  as  strengthening  the  defenses
gainst  oxidative  stress.6
11
1
1
1
1
1
1
1
1
2
2
2
2
2
2Maternal  supplementation  with  -tocopherol  
The  study  shows  that  supplementation  with  400  IU  of
-tocopherol  in  the  postpartum  promotes  an  increase  in
-tocopherol  concentrations  in  colostrum,  a  crucial  phase
for  the  neonate.  Therefore,  supplementation  is  recom-
mended  for  women  in  the  postpartum  period,  with  a
mega  dose  >400  IU  or  daily  supplementation  at  doses  that
meet  the  DRI,  in  order  to  meet  the  needs  of  all  the
mothers.
Although  supplementation  provides  an  increase  in
-tocopherol  levels,  factors  that  interfere  with  this  supple-
mentation  have  not  been  investigated,  particularly  vitamin
E  and  fat  intake  during  pregnancy,  which  can  be  considered
a  study  limitation.  Another  factor  to  be  taken  into  consid-
eration  is  that,  because  it  is  a  cross-sectional  study,  it  was
not  possible  to  verify  the  possibility  of  maintaining  vitamin
E  levels  during  other  stages  of  lactation.
Funding
Conselho  Nacional  de  Desenvolvimento  Cientíﬁco  e Tec-
nológico  --  CNPQ.
Conﬂicts of interest
The  authors  declare  no  conﬂicts  of  interest.
References
1. Traber MG. Vitamin E. In: Bowman BA, Russell RM, editors.
Present knowledge in nutrition. 9th ed. Washington: ILSI Press;
2006. p. 211--9.
2. Sánchez-Pérez A, Delgado-Zamarren˜o MM, Bustamante-Rangel
M, Hernández-Méndez J. Automated analysis of vitamin E iso-
mers in vegetable oils by continuous membrane extraction
and liquid chromatography-electrochemical detection. J Chro-
matogr A. 2000;881:229--41.
3. Gomes MM, Saunders C, Accioly E. Vitamin A role prevent-
ing oxidative stress in newborns. Rev Bras Saude Mater Infant.
2005;5:275--82.
4. Institute of Medicine. Dietary reference intakes for vitamin
C, vitamin E, selenium, and carotenoids. Washington (DC):
National Academy Press; 2003.
5. Didenco S, Gillingham MB, Go MD, Leonard SW, Traber
MG, McEvoy CT. Increased vitamin E intake is associated
with higher -tocopherol concentration in the maternal
circulation but higher -carboxyethylhydroxychroman concen-
tration in the fetal circulation. Am J Clin Nutr. 2011;93:
368--73.
6. Schweigert FJ, Bathe K, Chen F, Büscher U, Dudenhausen JW.
Effect of the stage of lactation in humans on carotenoid levels
in milk, blood plasma and plasma lipoprotein fractions. Eur J
Nutr. 2004;43:39--44.
7. Antonakou A, Chiou A, Andrikopoulos NK, Bakoula C, Mata-
las AL. Breast milk tocopherol content during the ﬁrst six
months in exclusively breastfeeding Greek women. Eur J Nutr.
2011;50:195--202.
8. Macias C, Schweigert FJ. Changes in the concentration on
of carotenoids, vitamin A, alpha-tocopherol and total lipids
in human milk throughout early lactation. Ann Nutr Metab.
2001;45:82--5.
9. Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation
for prevention of morbidity and mortality in preterm infants.
Cochrane Database Syst Rev. 2003;4:1--102.
245
0. Ortega RM, López-Sobaler AM, Martínez RM, Andrés P, Quin-
tas ME. Inﬂuence of smoking on vitamin E status during the
third trimester of pregnancy and on breast-milk tocopherol
concentrations in Spanish women. Am J Clin Nutr. 1998;68:
662--7.
1. Romeu-Nadal M, Morera-Pons S, Castellote AI, López-Sabater
MC. Determination of - and -tocopherols in human milk
by a direct high-performance liquid chromatographic method
with UV--vis detection and comparison with evaporative
light scattering detection. J Chromatogr A. 2006;1.114:
132--7.
2. Bauer J, Gerss J. Longitudinal analysis of macronutrients and
minerals in human milk produced by mothers of preterm infants.
Clin Nutr. 2011;30:215--20.
3. Sauberlich HE. Laboratory tests for the assessment of nutritional
status. Series: modern nutrition, 2nd ed. Boca Raton (FL): CRC
Press; 1999.
4. Silva LS, Thiapó AP, Souza GG, Saunders C, Ramalho A. Micronu-
trientes na gestac¸ão e lactac¸ão. Rev Bras Saude Mater Infant.
2007;7:237--44.
5. Papas A, Stacewicz-Sapuntzakis M, Lagiou P, Bamia C, Chloptsios
Y, Trichopoulou A. Plasma retinol and tocopherol levels in rela-
tion to demographic, lifestyle and nutritional factors of plant
origin in Greece. Br J Nutr. 2003;89:83--7.
6. Garcia LR, Ribeiro KD, Araújo KF, Azevedo GM, Pires JF, Batista
SD, et al. Níveis de alfa-tocoferol no soro e leite maternos
de puérperas atendidas em maternidade pública de Natal,
Rio Grande do Norte. Rev Bras Saude Mater Infant. 2009;9:
423--8.
7. Dimenstein R, Pires JF, Garcia LR, Lira LQ. Concentrac¸ão de alfa-
tocoferol no soro e colostro materno de adolescentes e adultas.
Rev Bras Ginecol Obstet. 2010;32:267--72.
8. de Lira LQ, Ribeiro PP, Grilo EC, Lima MS, Dimenstein R.
Níveis de alfa-tocoferol no soro e colostro de lactantes e
associac¸ão com variáveis maternas. Rev Bras Ginecol Obstet.
2012;34:362--8.
9. Campos JM [Dissertation] Perﬁl dos níveis de vitaminas A e E
no leite de doadoras primíparas e multíparas em bancos de
leite humano. Recife, PE: Universidade Federal de Pernambuco;
2005.
0. Maras JE, Bermudez OI, Qiao N, Bakun PJ, Boody-Alter EL,
Tucker KL. Intake of alpha-tocopherol is limited among US
adults. J Am Diet Assoc. 2004;104:567--75.
1. To Tokus¸og˘lu O, Tansug˘ N, Aks¸it  S, Dinc¸  G, Kasirga E, Ozcan C.
Retinol and -tocopherol concentrations in breast milk of Turk-
ish lactating mothers under different socio-economic status. Int
J Food Sci Nutr. 2008;59:166--74.
2. Szlagatys-Sidorkiewicz A, Zagierski M, Jankowska A, Łuczak G,
Macur K, Ba˛czek T, et al. Longitudinal study of vitamins A, E
and lipid oxidative damage in human milk throughout lactation.
Early Hum Dev. 2012;88:421--4.
3. Martysiak-Zurowska D, Szlagatys-Sidorkiewicz A, Zagierski
C. Concentrations of alpha- and gamma-tocopherols in
human breast milk during the ﬁrst months of lacta-
tion and in infant formulas. Matern Child Nutr. 2013;9:
473--82.
4. Tijerina-Sáenz A, Innis SM, Kitts DD. Antioxidant capac-
ity of human milk and its association with vitamins A
and E and fatty acid composition. Acta Paediatr. 2009;98:
1793--8.
5. Garcia L, Ribeiro K, Araújo K, Pires J, Azevedo G, Dimen-
stein R. Alpha-tocopherol concentration in the colostrum of
nursing women supplemented with retinyl palmitate and alpha-
tocopherol. J Hum Nutr Diet. 2010;23:529--34.
6. Kitajima H, Kanazawa T, Mori R, Hirano S, Ogihara T, Fujimura M.
Long-term alpha-tocopherol supplements may improve mental
development in extremely low birthweight infants. Acta Paedi-
atr. 2015;104:e82--9.
42
2
26  
7. Chen K, Zhang X, Wei XP. Antioxidant vitamin status during preg-
nancy in relation to cognitive development in the ﬁrst two years
of life. Early Hum Dev. 2009;85:421--7.
8. Hartnett ME, Penn JS. Mechanisms and management of
retinopathy of prematurity. N Engl J Med. 2012;367:
2515--26.
3Melo  LR  et  al.
9. Grummer-Strawn LM, Rollins N. Summarising the health effects
of breastfeeding. Acta Paediatr. 2015;104:1--2.0. Clemente HA, Ramalho HM, Lima MS, Grilo EC, Dimenstein R.
Maternal supplementation with natural or synthetic vitamin E
and its levels in human colostrum. J Pediatr Gastroenterol Nutr.
2015;60:533--7.
